Text Size
1967 studies found for:    Open Studies | "Drug Therapy"

Modify this search | How to Use Search Results

Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Drug Therapy" (1967 records)
Need help? See Downloading Content for Analysis
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Recruiting Fosaprepitant in Patients Receiving Ifosfamide-based Regimen
Conditions: Sarcoma;   Chemotherapy-induced Nausea and Vomiting;   Effects of Chemotherapy;   Adverse Effects of Medical Drugs
Interventions: Drug: Fosaprepitant;   Drug: Dexamethasone;   Drug: 5HT3 receptor antagonist;   Drug: Ifosfamide-based chemotherapy (AI);   Drug: Doxorubicin;   Drug: Mesna;   Drug: Ifosfamide;   Drug: Vincristine
2 Recruiting A Safety and Efficacy Study of Rolapitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Subjects Receiving Highly Emetogenic Chemotherapy
Condition: Chemotherapy-induced Nausea and Vomiting
Interventions: Drug: Rolapitant;   Drug: Granisetron;   Drug: Dexamethasone
3 Recruiting A Safety and Efficacy Study of Rolapitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Subjects Receiving Moderately Emetogenic Chemotherapy
Condition: Chemotherapy-induced Nausea and Vomiting
Interventions: Drug: Rolapitant;   Drug: Granisetron;   Drug: Dexamethasone
4 Recruiting Phase 3 Safety and Efficacy Study of Rolapitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Subjects Receiving Highly Emetogenic Chemotherapy
Condition: Chemotherapy-induced Nausea and Vomiting
Interventions: Drug: Rolapitant;   Drug: Granisetron;   Drug: dexamethasone
5 Recruiting Effect of Yoga in Reducing Chemotherapy Induced Nausea and Vomiting
Conditions: Breast Cancer;   Malignant Female Reproductive System Neoplasm;   Lymphomas;   Chemotherapy-induced Nausea and Vomiting
Interventions: Behavioral: yoga;   Behavioral: Jacobsons PMRT group
6 Recruiting Phase 4 Trial to Evaluate the Efficacy and Safety of Sancuso Patch in Chemotherapy-induced Nausea and Vomiting Associated With the Administration of Highly Emetogenic Chemotherapy (HEC)
Condition: Chemotherapy-induced Acute or Delayed Nausea and Vomiting (CINV)
Interventions: Drug: Sancuso patch;   Drug: Zofran inj.+Zofran tab.
7 Recruiting Neoadjuvant Erbitux Based Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer
Conditions: Locally Advanced Malignant Neoplasm;   Oral Cancer;   Oropharyngeal Carcinoma;   Effects of Chemotherapy
Intervention: Drug: Neo-adjuvant Erbitux-based chemotherapy
8 Recruiting Primary Chemotherapy With Anthracycline Followed by Nab-paclitaxel and Trastuzumab
Conditions: Breast Cancer;   HER-2 Positive Breast Cancer;   Effects of Chemotherapy
Intervention: Drug: Nab-paclitaxel
9 Unknown † A Pilot Study to Evaluate the Safety and Activities of EW02 in Reducing Neutropenia Caused by Chemotherapy
Conditions: Breast Cancer;   Chemotherapy;   Neutropenia
Intervention: Other: EW02
10 Recruiting Effect of Enteral Nutrition Rich in Eicosapentaenoic Acid (EPA) on Patients Receiving Chemotherapy for GI Tumor
Conditions: Gastric Cancer;   Colorectal Cancer;   Chemotherapy
Interventions: Drug: Nutriall;   Drug: LDEPA;   Drug: Placebo;   Drug: HDEPA;   Drug: Chemotherapy
11 Unknown † Low-Dose/Metronomic(LDM)Chemotherapy for Metastatic Breast Cancer
Conditions: Chemotherapy;   Breast Cancer, Metastatic
Intervention: Drug: Cyclophosphamide, Capecitabine, Methotrexate, Celecoxib, Pamidronate (or Zoledronate)
12 Recruiting Observational Studies of the Application of Bevacizumab in HER2-negative Breast Cancer Neoadjuvant Chemotherapy
Conditions: Breast Cancer;   Bevacizumab;   Neoadjuvant Chemotherapy;   Molecular Targeted Therapy
Intervention: Drug: bevacizumab
13 Recruiting A Study of Intravenous Iron Isomaltoside 1000 (Monofer®) as Mono Therapy (Without Erythropoeisis Stimulating Agents) in Comparison With Oral Iron Sulfate in Subjects With Non-myeloid Malignancies Associated With Chemotherapy Induced Anaemia (CIA)
Conditions: Non-myeloid Malignancies;   Chemotherapy Induced Anaemia
Interventions: Drug: iron isomaltoside 1000;   Drug: iron sulphate
14 Recruiting Tailored Neoadjuvant Chemotherapy for Stage II/III Breast Cancer With Tumor Size More Than 2 cm
Conditions: Breast Cancer;   Chemotherapy
Interventions: Drug: Taxotere , Epirubicin;   Drug: E-HDFL,EP,TE,N-HDFL,NP,T-HDFL,TP
15 Recruiting LYmphadenectomy After NeoAdjuvant Chemotherapy
Condition: Advanced Ovarian Cancer (Stage III or IV) After Neoadjuvant Chemotherapy
Intervention: Procedure: Systematic pelvic and aortic lymphadenectomy
16 Recruiting Characterization and Treatment of Chemotherapy Neuropathy
Condition: Chemotherapy-induced Neuropathy
Interventions: Procedure: Photon stimulation;   Procedure: Placebo treatment
17 Recruiting Phase 4 Trial to Evaluate the Efficacy and Safety of Sancuso Patch in CINV (Chemotherapy-induced Nausea and Vomiting) Associated With the Administration of MEC (Moderately Emetogenic Chemotherapy)
Condition: Chemotherapy-induced Acute or Delayed Nausea and Vomiting (CINV)
Interventions: Drug: Sancuso patch;   Drug: Kytril inj.+Kytril tab.
18 Not yet recruiting Olaparib Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.
Conditions: Newly Diagnosed;   Advanced Ovarian Cancer;   FIGO Stage II-IV;   BRCA Mutation;   Complete Response;   Partial Response;   First Line Platinum Chemotherapy
Intervention: Drug: Olaparib 300mg tablets
19 Unknown † Evaluation of Maxy-G34 in Breast Cancer Patients Treated With TAC (Docetaxel, Adriamycin, Cyclophosphamide) Chemotherapy
Conditions: Chemotherapy-Induced Neutropenia;   Breast Cancer
Intervention: Biological: Maxy-G34
20 Recruiting Phase III Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced Neutropenia
Condition: Chemotherapy Induced Neutropenia
Interventions: Drug: PEG-G-CSF;   Drug: G-CSF
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years